- Projects & figures
- News & Events
- Managing your project
- About ERC
Until recently, lungs were believed to be sterile, but today we know that they are inhabited by microbes migrating from the mouth. Dr Randi Bertelsen has been awarded an ERC grant to investigate the role played by the oral microbiome in lung disease.
ELECTION SERIES #5
One would not be mistaken to assume that traditional party politics has become side‑lined by the rise of an angrier, more direct form of protest politics, supercharged by years of austerity following the financial crash of 2008-2009. One ERC-funded project, POLPART, has been dedicated to understanding how and why people become engaged in politics and what this means for ongoing efforts to strengthen and preserve our democracies for the future.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
On 30 November and 1st December, the G20 2018 Summit will take place in Buenos Aires, Argentina. The leaders and Ministers of finances of the World's major economies, including the European Union, will address the pressing concerns and challenges related to the global economy and finances. In this high decision-making forum, Prof. Irma Mosquera Valderrama has managed to make a place for her independent expertise, raising the voices of developing countries.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.
Regulating migration has become a key priority for European countries and, according to Prof. Katja Franko, crime control practices and penal cultures have evolved across the continent as a consequence. With ERC support, she has studied these new hybrid and intertwined forms of migration and crime control policies, a phenomenon she calls ‘Crimmigration control’.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Many children of migrants, born in their adopted homeland, have successfully overcome the odds and enjoy ‘elite’ status with well paid jobs in EU countries. By studying these individuals, researchers hope to identify how policies and education can be changed to help more second-generation migrants achieve success.
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.